Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers
Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 50.5% to $0.20 in pre-market trading after dropping 5% on Wednesday.
Expert Ratings for Spectrum Pharma
Analysts have provided the following ratings for Spectrum Pharma (NASDAQ:SPPI) within the last quarter: Bullish Somewhat Bullish Indifferent…
Dow Dips Over 300 Points; McDonald’s Beats Q1 Expectations
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Tuesday.
The Dow traded down 0.92% to 33,562.53 while the NASDAQ fell 1.75% to 11,826.47. The S&P 500, also fell, dropping, 1.40% to 4,079.31.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Petros Pharma (NASDAQ:PTPI) shares moved upwards by 48.8% to $5.71 during Tuesday’s regular session. Trading volume for…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Virios Therapeutics (NASDAQ:VIRI) shares moved upwards by 93.5% to $1.21 during Tuesday’s pre-market session. The market value…
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers
RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket
Gainers
Ibio Inc (NYSE: IBIO) shares rose 162.6% to $1.97 in pre-market trading after dropping around 12% on Thursday. JMP Securities, on Thursday, downgraded iBio from Market Outperform to Market Perform.
Cantor Fitzgerald Maintains Neutral on Spectrum Pharmaceuticals, Lowers Price Target to $0.75
Cantor Fitzgerald analyst Prakhar Agrawal maintains Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Neutral and lowers the price target from $3 to $0.75.
JMP Securities Reiterates Market Outperform on Spectrum Pharmaceuticals, Maintains $4 Price Target
JMP Securities analyst Reni Benjamin reiterates Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Market Outperform and maintains $4 price target.